Analytical Chromatography Segment to Account for 43.63% Global Pharmaceutical Grade Silica Gel Market Share

 

Silica gel is a polar, slightly acidic adsorbent with a high capacity to adsorb the basic material. The most common application of the silica gel is in reversed-phase partition chromatography, where it is used to separate steroids, amino acids, lipids, alkaloids, and various medicinal processes. Silica gel improves antibiotic formulations' shelf life and storage stability by protecting them from water vapor and moisture. This will assist in increasing demand. The pharmaceutical industry's expansion will continue to be a major growth contributor in the foreseeable future.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-pharmaceutical-grade-silica-gel-market

Data Bridge Market Research analyses that the pharmaceutical grade silica gel market is expected to grow at a CAGR of 3.1% in the forecast period of 2022 to 2029 and is expected to reach USD 158,681.13 thousand by 2029. The global pharmaceutical grade silica gel market is estimated to rise significantly over the forecast period, owing to increased demand from key application sectors such as desiccants, drug carriers, and adsorbents. The pharmaceutical industry's general expansion is anticipated to be the primary driver of this growth.  

Pharmaceutical Grade Silica Gel Market

Rising investments and initiatives from the pharmaceutical industry are expected to drive the market's growth rate during the forecast period.

One of the most important factors driving the pharmaceutical grade silica gel market is government initiatives and investments. For instance, the Indian government launched the Atal Innovation Mission to develop new complicated generic pharmaceuticals complemented by the New Drugs and Clinical Trial Rules, 2019. These types of initiatives help to boost the manufacture of medications, medical devices, and equipment, which drives the pharmaceutical grade silica gel market. Singapore's government has pledged a USD 4.2 billion investment in pharmaceutical industry development. Circa Pharmaceuticals Inc. has committed USD 20 billion over the next few years to the development of Indonesia's pharmaceutical industry. Such expenditures and initiatives boost drug production, which is propelling the growth rate of the pharmaceutical-grade silica gel market.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Thousand, Volumes in Units, Pricing in USD

Segments Covered

Type (Liquid And Solid), Gel Breads Type (White Silica Gel Breads, Orange Silica Gel Breads, and Blue Silica Gel Breads), Form (Colorants, Lubricants & Glidants, Binders, Disintegrants, Flavoring Agents, Capsules, Solvents, Coatings, Preservatives, Fillers & Diluents, Suspension, Viscosity Agents And Others), Packaging Type (Canisters, Pouches, Sachets, Packets, Containers, Bottles, and Others), Chromatography (Analytical Chromatography, Preparative Chromatography, Process Chromatography, and Gravity Chromatography)

Countries Covered

U.S., Canada, Mexico Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia & New Zealand and Rest of Asia-Pacific, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, Luxemburg, and Rest of Europe, Brazil, Argentina, and Rest of South America, South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, and Rest of Middle East and Africa

Market Players Covered

Merck KGaA (Germany),  BASF SE (Germany), DuPont (U.S.), Evonik Industries AG (Germany), Solvay (Belgium), W. R. Grace & Co.-Conn (U.S.), Multisorb Technologies (U.S.), Clariant AG (Switzerland), Fuji Silysia Chemical (Japan)

Data Pointers Covered in Report

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and climate chain scenario.

Segment Analysis:

The pharmaceutical grade silica gel market is segmented on the basis of type, gel breads type, form, packaging type, and chromatography.  

  • On the basis of type, the global pharmaceutical grade silica gel market is segmented into solid and liquid. In 2022, the solid segment is expected to dominate the global pharmaceutical grade silica gel market with a 63.69% market share because amorphous solid silica gel is non-reactive in nature and does not react with substance in chromatography technique.

In 2022, the solid segment is projected to hold the largest share of type segment in the pharmaceutical grade silica gel market

In 2022, the solid segment is anticipated to hold the largest share of the global pharmaceutical grade silica gel market because amorphous solid silica gel is non-reactive and does not react with substance in chromatography technique. The solid segment is growing with a CAGR of 3.3% in the forecast period of 2022 to 2029.

  • On the basis of gel beads, the global pharmaceutical grade silica gel market is segmented into white silica gel beads, orange silica gel beads, and blue silica gel beads. In 2022, the white silica gel beads segment is expected to dominate the global pharmaceutical grade silica gel market with a 61.89% market share as white silica gel beads have a high surface area and have a vast network of narrow interconnecting pores which have a strong affinity for moisture.

In 2022, the white silica gel beads segment of gel beads segment is anticipated to dominate the pharmaceutical grade silica gel market.

In 2022, the white silica gel beads segment of this market will dominate the pharmaceutical grade silica gel market as white silica gel beads have a high surface area and have a vast network of narrow interconnecting pores which have a strong affinity for moisture. The white silica gel beads segment is expected reach the highest CAGR of 3.3% in the forecast period of 2022-2029.

  • On the basis of form, the global pharmaceutical grade silica gel market is segmented into fillers & diluents, binders, disintegrants, lubricants & glidants, colorants, flavoring agents, preservatives, solvents, capsules, viscosity agents, suspension, and coatings. In 2022, the fillers & diluents segment is expected to dominate the global pharmaceutical grade silica gel market with a 20.46% market share because of its inert characteristics which affect the chemical and physical properties of the final tablet thus affecting the biopharmaceutical profile.
  • On the basis of packaging type, the global pharmaceutical grade silica gel market is segmented into pouches, sachets, packets, canisters, containers, bottles, and others. In 2022, the pouches segment is expected to dominate the global pharmaceutical grade silica gel market with a 35.56% market share because pouches are used in a wide range of applications, including medicines storage, surgical instruments, and other pharmaceutical products.
  • On the basis of chromatography, the global pharmaceutical grade silica gel market is segmented into analytical chromatography, preparative chromatography, process chromatography, and gravity chromatography. In 2022, the analytical chromatography segment is expected to dominate the global pharmaceutical grade silica gel market with a 43.63% market share. Silica gel is widely used in different analytical techniques of chromatography such as column chromatography purification and separation of compounds in the pharmaceutical and chemical industry.

Major Players

Data Bridge Market Research recognizes the following companies as the major pharmaceutical grade silica gel market players in pharmaceutical grade silica gel market are Merck KGaA (Germany),  BASF SE (Germany), DuPont (U.S.), Evonik Industries AG (Germany), Solvay (Belgium), W. R. Grace & Co.-Conn (U.S.), Multisorb Technologies (U.S.), Clariant AG (Switzerland), Fuji Silysia Chemical (Japan).

Pharmaceutical Grade Silica Gel Market

Market Development -

  • In August 2020, Evonik had announced the acquisition of Porocel for USD 210 million to enhance the growth of catalysts business. Porocel provides Evonik with catalyst rejuvenation technology as well as available production capacity. Catalyst rejuvenation lowers CO2 emissions while promoting a circular economy. The acquisition sharpens the portfolio's focus on stable, high-margin specialty chemicals.

Regional Analysis

Geographically, the countries covered in the pharmaceutical grade silica gel market report are U.S., Canada, Mexico Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia & New Zealand and Rest of Asia-Pacific, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, Luxemburg, and Rest of Europe, Brazil, Argentina, and Rest of South America, South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, and Rest of Middle East and Africa.

As per Data Bridge Market Research analysis:

Asia-Pacific is the dominant region in pharmaceutical grade silica gel market during the forecast period 2022 - 2029

Asia-Pacific will continue to dominate the pharmaceutical grade silica gel market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period due to the increasing demand from the pharmaceutical sectors for the packaging in the form of desiccants, canisters, and packets/bags. Additionally, rising market penetration of pharmaceutical ingredients and excipients in the specialty medicines as well as biotech companies in the region will further propel the market's growth rate.

North America is estimated to be the fastest-growing region in pharmaceutical grade silica gel market the forecast period 2022 - 2029

North America region is anticipated to grow at the highest rate during the forecast period of 2022-2029 due to the presence of major key players in this region. Along with this, the rising level of disposable income is anticipated to enhance the market's growth rate in this region.

COVID-19 Impact Analysis

The COVID-19 outbreak had a variety of effects on the pharmaceutical grade silica gel business, including production halts, stockpiles, supply chain blockages, and more. This has had a negative impact on the pharmaceutical grade silica gel sector, with key suppliers suffering significant losses. Due to the pandemic, global Foreign Direct Investments fell by much to 40% in 2020. On the other hand, the pharmaceutical grade silica gel market had increasing demand during the pandemic as it is widely utilized in the healthcare industry, and the healthcare industry was experiencing a boom at the time. Furthermore, there were restrictions on exports and imports due to pandemic-related restrictions. However, the pharmaceutical grade silica gel sector is recovering and will be profitable by 2022.

For more detailed information about the pharmaceutical grade silica gel market report, click here – https://www.databridgemarketresearch.com/reports/global-pharmaceutical-grade-silica-gel-market